QUADAS-2 tool for quality assessment in diagnostic meta-analysis
Letter to the Editor

QUADAS-2 tool for quality assessment in diagnostic meta-analysis

Qing-Xiu Huang, Xiao-Wen Huang

Zhongshan Hospital affiliated to Guangzhou University of Chinese Medicine, Zhongshan, China

Correspondence to: Dr. Xiao-Wen Huang. Zhongshan Hospital affiliated to Guangzhou University of Chinese Medicine, Zhongshan 528400, China. Email: hxiaow3@mail2.sysu.edu.cn.

Comment on: Xiang Y, Wang G, Zhou L, et al. A systematic review and meta-analysis on transvaginal ultrasonography in the diagnosis of deep invasive endometriosis. Ann Palliat Med 2022;11:281-90.


Submitted Feb 13, 2022. Accepted for publication Mar 25, 2022.

doi: 10.21037/apm-22-204


We read with great interest the recently published article titled “A systematic review and meta-analysis on transvaginal ultrasonography in the diagnosis of deep invasive endometriosis” (1). This meta-analysis indicated that transvaginal ultrasonography was useful to diagnose deep invasive endometriosis with high sensitivity (98%) and specificity (nearly 100%). After reading this article in detail, we have several questions.

In the “Quality assessment” section, the authors stated “The Quality Assessment of Diagnostic Accuracy Studies (QUADAS) recommended by the Cochrane Collaboration was used as a quality evaluation tool for diagnostic experiments to evaluate the risk of bias in the articles. As shown in Tab. 1...” (see page 283) with citing the literature (see reference 16 of original article) (2). However, we found that the citation actually described the QUADAS-2 tool (2), not the QUADAS as the author stated in the article, which was the old version in 2003 (3). QUADAS has been revised as QUADAS-2 in 2011 (2). Although the authors cited the literature of QUADAS-2 (2), the Tab. 1 of the original article was arranged according to the 2003 version of QUADAS (3). QUADAS-2 tool had been developed and refined after practice, and widely used to assess the quality of included studies in meta-analysis of diagnostic trials in recent years (4-6). The QUADAS-2 tool provided a presentation template of quality assessment results, which comprised 4 domains: patient selection, index test, reference standard, and flow and timing (2). Therefore, we suggested authors to use the QUADAS-2 tool to perform the quality assessment and present the results following the template provided by QUADAS-2 (2).

There were other issues. First, there were two “Data extraction” sections (see page 283), of which we thought the second “Data extraction” actually belonged to the “Statistical analysis”. Secondly, some data were not shown in the article. On page 283, the authors stated “The data extracted for this study included basic information of the articles...basic participant characteristics of the subjects...research methods...”, and “The sensitivity of the research results was analyzed by investigating whether a single study affected the overall results of the combination...”. But these data or results were not shown in the article. Thirdly, literature search was performed in several databases of “PubMed, Medline, and Embase...” (see page 282) but only “PubMed” record was shown in Fig. 1 of the original article. Were there no records searched from other databases? Fourth, what was the “Score” in Tab. 2 of the original article, it was not mentioned in the article.

Anyway, the authors concluded a clinically meaningful meta-analysis. We congratulate the authors on publishing their work in Annals of Palliative Medicine and sincerely look forward to the authors’ reply.


Acknowledgments

Funding: None.


Footnote

Provenance and Peer Review: This article was a standard submission to the journal. The article did not undergo external peer review.

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://apm.amegroups.com/article/view/10.21037/apm-22-204/coif). The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Xiang Y, Wang G, Zhou L, et al. A systematic review and meta-analysis on transvaginal ultrasonography in the diagnosis of deep invasive endometriosis. Ann Palliat Med 2022;11:281-90. [Crossref] [PubMed]
  2. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529-36. [Crossref] [PubMed]
  3. Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25. [Crossref] [PubMed]
  4. Muzembo BA, Kitahara K, Debnath A, et al. Accuracy of cholera rapid diagnostic tests: a systematic review and meta-analysis. Clin Microbiol Infect 2022;28:155-62. [Crossref] [PubMed]
  5. Kassirian S, Hinton SN, Cuninghame S, et al. Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis. Thorax 2022; Epub ahead of print. [Crossref] [PubMed]
  6. van der Pol CB, McInnes MDF, Salameh JP, et al. CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis. Radiology 2022;302:326-35. [Crossref] [PubMed]
Cite this article as: Huang QX, Huang XW. QUADAS-2 tool for quality assessment in diagnostic meta-analysis. Ann Palliat Med 2022;11(5):1844-1845. doi: 10.21037/apm-22-204

Download Citation